Celsius Holdings, Inc. (NASDAQ:CELH – Get Free Report) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 28,730,000 shares, an increase of 14.1% from the October 15th total of 25,170,000 shares. Based on an average trading volume of 7,670,000 shares, the short-interest ratio is currently 3.7 days.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on CELH. Stifel Nicolaus decreased their price target on shares of Celsius from $51.00 to $45.00 and set a “buy” rating on the stock in a research note on Thursday, November 7th. Jefferies Financial Group lowered their target price on shares of Celsius from $53.00 to $48.00 and set a “buy” rating on the stock in a research note on Thursday, October 10th. TD Cowen dropped their price target on shares of Celsius from $68.00 to $50.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Truist Financial lifted their price objective on Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a report on Wednesday, October 16th. Finally, Piper Sandler dropped their target price on Celsius from $50.00 to $47.00 and set an “overweight” rating for the company in a report on Tuesday, September 24th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $54.40.
Get Our Latest Stock Analysis on Celsius
Celsius Stock Performance
Insider Transactions at Celsius
In other Celsius news, CEO John Fieldly sold 74,847 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the sale, the chief executive officer now owns 1,812,490 shares in the company, valued at approximately $59,449,672. This trade represents a 3.97 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.20% of the stock is currently owned by corporate insiders.
Institutional Trading of Celsius
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its position in shares of Celsius by 3.6% during the 3rd quarter. Geode Capital Management LLC now owns 3,000,805 shares of the company’s stock worth $93,928,000 after buying an additional 104,896 shares during the period. M&T Bank Corp boosted its stake in Celsius by 49.3% in the third quarter. M&T Bank Corp now owns 30,765 shares of the company’s stock valued at $965,000 after acquiring an additional 10,159 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in Celsius during the 3rd quarter worth $301,000. XTX Topco Ltd raised its position in shares of Celsius by 119.8% during the 3rd quarter. XTX Topco Ltd now owns 21,431 shares of the company’s stock valued at $672,000 after acquiring an additional 11,681 shares during the last quarter. Finally, iA Global Asset Management Inc. acquired a new position in shares of Celsius in the 3rd quarter valued at $2,772,000. 60.95% of the stock is currently owned by institutional investors and hedge funds.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Articles
- Five stocks we like better than Celsius
- Investing In Preferred Stock vs. Common Stock
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Election Stocks: How Elections Affect the Stock Market
- Time to Load Up on Home Builders?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.